Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
1 other identifier
interventional
425
1 country
3
Brief Summary
Assess precision of the i-STAT potassium (K) and ionized calcium (iCa) tests using i-STAT CG8+ cartridge on the i-STAT 1 analyzer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 17, 2025
CompletedFirst Submitted
Initial submission to the registry
December 4, 2025
CompletedFirst Posted
Study publicly available on registry
December 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
December 17, 2025
August 1, 2025
11 months
December 4, 2025
December 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Precision assessment
Assess the precision of the i-STAT potassium (K) and ionized calcium (iCa) tests in mmol/L with the investigational use only (IUO) i-STAT CG8+ cartridge on the i-STAT 1 analyzer using results from capillary specimens from each subject enrolled in the study.
Thirty (30) minutes from subject enrollment to the end of the blood draw and testing.
Study Arms (1)
Precision of potassium (K) and ionized calcium (iCa) tests in capillary blood
OTHERPrecision evaluation of the i-STAT K test and the i-STAT iCa test using i-STAT CG8+ cartridge on i-STAT 1 analyzer with capillary specimens from each subject enrolled in the study.
Interventions
Capillary whole blood specimens collected from fingerstick(s) will be collected from each enrolled subject with blood collection capillary tubes.
Eligibility Criteria
You may qualify if:
- Signed and dated consent form (waiver/alteration of consent, waiver of documentation of consent may be acceptable, per IRB)
- ≥ 18 years of age
You may not qualify if:
- \. Previous enrollment in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University of New Mexico
Albuquerque, New Mexico, 87131, United States
Penn State Health Milton S. Hershey Medical Center (Hershey)
Hershey, Pennsylvania, 17033, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Study Officials
- STUDY DIRECTOR
Manish Gupta, MS, MBA
Abbott Point of Care
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2025
First Posted
December 17, 2025
Study Start
September 17, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
December 17, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share